arsenic trioxide has been researched along with Sensitivity and Specificity in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, B; Xing, M | 1 |
| Petrie, K; Waxman, S; Zelent, A | 1 |
| Gambacurta, A; Garaci, E; Lucibello, M; Pierimarchi, P; Rasi, G; Rubartelli, A; Serafino, A; Zonfrillo, M | 1 |
| Hariganesh, MR; Jeevan, RG; Radhakrishnan, G; Subramanian, NH | 1 |
| Cang, H; Wang, XJ; Yang, J; Yi, J; Zou, YQ | 1 |
| Andreeff, M; Carew, JS; Huang, P; Keating, MJ; McQueen, TJ; Pelicano, H; Plunkett, W | 1 |
| Kwong, YL; Leung, J; Pang, A; Tse, EW; Yuen, WH | 1 |
| Ammatuna, E; Lo Coco, F; Sanz, MA | 1 |
| Scheinberg, DA | 1 |
2 review(s) available for arsenic trioxide and Sensitivity and Specificity
| Article | Year |
|---|---|
Differentiation therapy of acute myeloid leukemia: past, present and future.
Topics: Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Humans; Leukemia, Myeloid, Acute; Oxides; Receptors, Retinoic Acid; Retinoic Acid Receptor alpha; Sensitivity and Specificity; Tretinoin | 2009 |
Old, new drugs and new, new drugs for the new millennium.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Benzamides; Clinical Trials as Topic; Female; Forecasting; Humans; Imatinib Mesylate; Leukemia, Promyelocytic, Acute; Male; Oxides; Piperazines; Prognosis; Pyrimidines; Sensitivity and Specificity; Treatment Outcome | 2000 |
7 other study(ies) available for arsenic trioxide and Sensitivity and Specificity
| Article | Year |
|---|---|
Evaluated the Twenty-Six Elements in the Pectoral Muscle of As-Treated Chicken by Inductively Coupled Plasma Mass Spectrometry.
Topics: Animals; Arsenic Trioxide; Arsenicals; Chickens; Environmental Pollutants; Mass Spectrometry; Oxides; Pectoralis Muscles; Sensitivity and Specificity; Trace Elements | 2016 |
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death.
Topics: Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Cell Death; Dose-Response Relationship, Drug; Glutathione; Humans; Hydrogen Peroxide; Oxidative Stress; Oxides; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured; Tumor Protein, Translationally-Controlled 1 | 2011 |
Simultaneous determination of arsenite and arsenate in arsenic trioxide injection by dual detection ion chromatography.
Topics: Antineoplastic Agents; Arsenates; Arsenic Trioxide; Arsenicals; Arsenites; Chromatography, Ion Exchange; Drug Contamination; Drug Stability; Electric Conductivity; Equipment Design; Oxides; Reproducibility of Results; Sensitivity and Specificity | 2011 |
Gene expression alteration during redox-dependent enhancement of arsenic cytotoxicity by emodin in HeLa cells.
Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Survival; Dose-Response Relationship, Drug; Emodin; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; HeLa Cells; Humans; Microarray Analysis; Oxidation-Reduction; Oxides; Reactive Oxygen Species; RNA, Messenger; Sensitivity and Specificity; Time Factors | 2005 |
Targeting Hsp90 by 17-AAG in leukemia cells: mechanisms for synergistic and antagonistic drug combinations with arsenic trioxide and Ara-C.
Topics: Acute Disease; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Benzoquinones; Cytarabine; DNA; Drug Administration Schedule; Drug Antagonism; Drug Screening Assays, Antitumor; Drug Synergism; Drug Therapy, Combination; G1 Phase; HeLa Cells; HSP90 Heat-Shock Proteins; Humans; Jurkat Cells; Lactams, Macrocyclic; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myeloid; Oxides; Sensitivity and Specificity; Structure-Activity Relationship; Tumor Cells, Cultured | 2006 |
Relationship of expression of aquaglyceroporin 9 with arsenic uptake and sensitivity in leukemia cells.
Topics: Acute Disease; Aquaporins; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Proliferation; Gene Expression Profiling; Humans; K562 Cells; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Oxides; Point Mutation; Reverse Transcriptase Polymerase Chain Reaction; Sensitivity and Specificity; Tretinoin; Up-Regulation | 2007 |
Current treatment of acute promyelocytic leukemia.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Arsenic Trioxide; Arsenicals; Biomarkers, Tumor; Clinical Trials as Topic; Computer Systems; Disease Management; Drug Monitoring; Hematopoietic Stem Cells; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Mice; Multicenter Studies as Topic; Oncogene Proteins, Fusion; Oxides; Polymerase Chain Reaction; Predictive Value of Tests; Recurrence; Sensitivity and Specificity; Transfection; Tretinoin | 2007 |